Last reviewed · How we verify

NCT05409170

The Change of Clinical Features and Surgical Outcomes in Patients With Pressure Injury During the COVID-19 Pandemic: A Retrospective Study

Completed Last updated 8 June 2022
What this trial tests

trial testing COVID in Pressure Injury in 213 participants. Completed in 31 May 2022.

Timeline
1 January 2016
Primary endpoint
1 December 2021
31 May 2022

Quick facts

Lead sponsorTaipei Medical University WanFang Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment213
Start date1 January 2016
Primary completion1 December 2021
Estimated completion31 May 2022

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Medical University WanFang Hospital

Who can join

20 and older, any sex, with Pressure Injury or COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The COVID-19 pandemic has considerably and negatively affected numerous lives and economies worldwide; specifically, it has led to delays in seeking medical treatment among many people \[1-3\]. Delaying or avoiding seeking medical advice can result in worsened symptoms, delayed evaluation, and treatment complications \[4-7\]. Moreover, the pandemic has significantly impacted health-care systems, leading to numerous issues including shortages of medical staff, beds, equipment, medicines, and isolation facilities. The concern of cross-contamination-where COVID-19 may spread within wards unknowingly-has also increased the emotional burden among health-care workers \[8-10\]. Pressure injury (PI) is a common health issue particularly among older people who have physical limitations or are bedridden. PI management often requires a long-term individualized plan. Failure to implement this strategy may influence the quality of life and may cause wound-related psychosocial issues (e.g., low self-esteem), increase health-care expenditures, and shorten survival among the patients \[11\]. Moreover, long-term PIs are prone to infection and bleeding, which may lead to sepsis or anemia \[12-14\]. The current study explored whether COVID-19 pandemic-related changes affected the characteristics and treatment outcomes of patients with PIs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The change of clinical features and surgical outcomes in patients with pressure injury during the COVID-19 pandemic.
    Huang CY, Chang CW, Lee SL, Chen C, et al · · 2023 · cited 3× · PMID 36054743 · DOI 10.1111/iwj.13944

Verify or expand the search:

Other trials of COVID

Trials testing the same drug.

Other recruiting trials for Pressure Injury

Currently open trials in the same condition.

Other Taipei Medical University WanFang Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05409170.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing